MRI test to map low-oxygen areas in childhood sarcomas
Part of Cancer clinical trials.
This Phase 1 study uses special MRI scans to look at “low-oxygen” parts of a childhood sarcoma. It aims to help doctors better understand the tumor before standard treatment that may include chemotherapy and sometimes radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed or suspected sarcoma (rhabdomyosarcoma or another non-rhabdomyosarcoma).
- Your tumor is outside the bone (an extra-osseous component).
- Your care team is planning neoadjuvant treatment before surgery, usually chemotherapy and possibly radiation.
- You can safely have an MRI scan (no incompatible metal/pacemakers, and you can tolerate the exam without sedation if needed).
- Your situation fits the main diagnosis and other major health exclusions do not apply.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different chemotherapy schedules for children and young adults with intermediate-risk rhabdomyosarcoma (a type of muscle cancer). One group gets a higher dose of chemotherapy over a shorter period, while the other gets a lower dose plus maintenance therapy for a longer time. The goal is to see which approach works better.
This Phase 2 trial looks at how two test approaches (an MRI-based scan and blood tests) work in people with a larger, grade 2 or 3 soft tissue sarcoma. It may help researchers learn better ways to measure the disease and guide care.
This study uses special MRI scans to see how oxygen levels inside a brain tumor change during radiotherapy. The goal is to help doctors target the radiation more precisely to the most active parts of the tumor.
This study tests a new MRI-based technique to better see the size and shape of bone sarcomas before surgery. The goal is to help surgeons remove all the cancer while saving as much healthy bone as possible.
This trial uses extra MRI scans during your 5 weeks of radiation therapy to see how the tumor responds. The goal is to better understand sarcoma biology and potentially guide future treatments.
This study uses special MRI scans to measure oxygen levels in and around glioblastoma before and during radiation treatment. It may help researchers understand how oxygen affects treatment response and timing.
Hear when a new Rhabdomyosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.